Kolovou et al evaluated possible gene polymorphisms of tumor protein p53 (TP53, rs1042522, p.Arg72Pro) that can differentiate patient with left main coronary artery disease (CAD) from patients with more peripheral CAD as well as from healthy participants. 1 They demonstrated that patients with left main CAD had lower Arg/Arg genotype frequencies compared to patients with more peripheral CAD as well as compared to controls (36.0% vs 57.3% vs 61.9%, respectively; P < .001 for both comparisons). Patients with left main CAD also had higher Arg/Pro TP53 gene polymorphisms compared to patients with more peripheral CAD as well as controls (56.0% vs 31.9% vs 33.8%, respectively; P < .001 for both comparisons).
1 They concluded that their study provides evidence linking variation in the TP53 gene with left main CAD phenotype risk. 1 An earlier study from South Africa also discussed by the authors 1 included 100 patients with CAD diagnosed by angiography, 100 age-and sex-matched Indian controls, and 84 ageand sex-matched black controls. 2 Genotype distribution differed significantly between patients with CAD and Indian controls (Pro/Pro, Pro/Arg, Arg/Arg: 24%, 48%, 28% vs 30%, 61%, 9% respectively, P ¼ .0025). There was also a significant genotype distribution between Indians and black controls (Pro/ Pro, Pro/Arg, Arg/Arg: 30%, 61%, 9% vs 45.2%, 40.5%, 14.3%, respectively, P ¼ .0212). The conclusion reached was TP53 gene polymorphism that was associated with CAD in young South Africans of Indian ancestry. 2 Another study from Italy (also discussed by the authors) 1 demonstrated a positive association between TP53 genotype (p53 codon 72) polymorphism with the presence of CAD. 3 The association between cardiovascular diseases and cancer is multifactorial. 4, 5 Many of the risk factors for the development of cardiovascular disease also predispose to the development of cancer (eg, smoking, hypercholesterolemia, obesity, and diabetes mellitus). 4, 5 The link between insulin resistance and cancer is well documented. 6, 7 Several epidemiological studies have demonstrated that the risk for several types of cancer (eg, breast, colorectal, liver, and pancreas) is higher in insulin-resistant patients. 6, 7 The study by Kolovou et al 1 adds to the existing literature 2, 3 suggesting that clinicians of different specialties (eg, cardiologists, oncologists, and vascular surgeons) should be aware of this association not only for the purpose of screening but also in terms of prevention measures. For example, there is evidence suggesting that statins may be associated with a reduced incidence of several forms of cancer (eg, colorectal, breast, and pancreatic cancer), 8 besides being an essential component in the management of cardiovascular diseases. [9] [10] [11] The study by Kolovou et al 1 extends our knowledge of the association between TP53 gene polymorphism with CAD to left main versus more peripheral CAD. As Kolovou et al also mention, 1 verification of the association between TP53 gene polymorphisms with CAD has important implications in terms of cancer and vascular disease prevention strategies. Finally, a key issue is that due to advances in treatment, there is prolonged survival rates for patients with cancer and cardiovascular disease. The association between TP53 gene polymorphisms with CAD presents an opportunity for increased awareness for the presence of both vascular disease and cancer.
